Holly Hendin
Psychiatry · Phoenix, AZNPI 1891990537
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $9,107 of the $9,911 with a category attached, or 91.9%. Biogen accounts for 66.9% of it on its own, with 9 other manufacturers making up the rest. Reporting peaked in 2022 at $6,800 and has fallen 99.0% since, to $71 in 2025. Among psychiatry clinicians in AZ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 28 payments — averaging $353.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Biogen$7K
- Sage Therapeutics, LLC$3K
- Vanda Pharmaceuticals Inc.$66
- Teva Pharmaceuticals USA, Inc.$54
- Sunovion Pharmaceuticals Inc.$51
- AbbVie$41
- plus $62 from 4 others
What the payments were for
- Consulting fees$9,10792%
- Food & beverage$8048%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Biogen | 2 | $6,633 |
| Sage Therapeutics, LLC | 7 | $3,004 |
| Vanda Pharmaceuticals Inc. | 4 | $66 |
| Teva Pharmaceuticals USA, Inc. | 4 | $54 |
| Sunovion Pharmaceuticals Inc. | 4 | $51 |
| AbbVie(2 entities) | 3 | $41 |
| Otsuka America Pharmaceutical, Inc. | 1 | $25 |
| Brainsway USA Inc | 1 | $14 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $12 |
| Shire North American Group Inc | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Zurzuvae$2,558
How this compares
$9,911 in reported general payments places this provider in the 95th percentile of 573 psychiatry providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Lamotrigine ErLamotrigine | 11 | $1,930 |
| Lamotrigine | 92 | $1,097 |
| Mirtazapine | 26 | $1,008 |
| Bupropion XlBupropion Hcl | 15 | $863 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 17 | $672 |
| Quetiapine Fumarate ErQuetiapine Fumarate | 16 | $503 |
| Fluoxetine Hcl | 19 | $469 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 14 | $412 |
| Duloxetine Hcl | 20 | $363 |
| Sertraline Hcl | 25 | $345 |
| Trazodone Hcl | 35 | $289 |
| Quetiapine Fumarate | 13 | $253 |
| Citalopram HbrCitalopram Hydrobromide | 12 | $152 |
| Amitriptyline Hcl | 19 | $124 |
Paid to pharmacies, not to this prescriber.
Other psychiatry in Phoenix
- Jason CaplanPhoenix$999K
- Thomas GazdaPhoenix$714K
- Monica BenavidezPhoenix$435K
- Eric ReimanPhoenix$157K
- Padma AkingPhoenix$44K
- Ahmed ElmaadawiPhoenix$32K
- Amnon KahanePhoenix$18K
- Aaron ClayPhoenix$14K
- Joel ParkerPhoenix$11K
- Ivan EngelPhoenix$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.